Unintentional weight loss (UWL) often presents a diagnostic challenge in clinical practice. It is a non-specific symptom associated with a wide range of conditions, from benign to life-threatening. This article aims to provide a comprehensive approach to evaluating unexplained weight loss in clinical practice.
Firstly, a thorough history and physical examination are crucial. This should include a detailed dietary history, medication review, and assessment of psychological factors. It is also important to consider the patient's age, as certain conditions such as malignancies are more common in older adults.
Basic laboratory investigations should include complete blood count, electrolyte panel, liver function tests, thyroid function tests, and urinalysis. Depending on the patient’s history and physical examination, more specific tests may be indicated, such as tumor markers or imaging studies.
In elderly patients, a common cause of UWL is the so-called "anorexia of aging," which is often multifactorial and includes decreased appetite, changes in taste and smell, and social factors. In these cases, a multidisciplinary approach involving dietitians, social workers, and possibly psychiatrists may be beneficial.
Patients with unexplained weight loss should be closely monitored. If initial investigations do not reveal a cause, consider repeating the investigations after a period of time or refer to a specialist. It is also important to monitor the patient's nutritional status and provide nutritional support if needed.
In conclusion, the evaluation of unexplained weight loss is a complex process that requires a systematic approach. A thorough history and physical examination, combined with targeted investigations, can help identify the underlying cause. Multidisciplinary involvement and close follow-up are also crucial in managing these patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation